Moreover, patient groups with altered NEDD4L expression showed a relatively shorter overall survival rate in pancreatic cancer patients, although this was not statistically significant (https://www.oncomine.org/). The gene discussed is NEDD4L; the disease is familial pancreatic carcinoma.